08/24/2014 - 4:27pm

Retail and supplier executives got their start before Meet the Market Saturday morning with Dan Mack, managing director of Mack Elevation Forum, who shared the six factors that make “dark horse” companies — small- to mid-tier companies that have carved out a successful business for themselves — great. 

08/24/2014 - 3:35pm

There’s no other aspect in business that would tolerate an 85% failure rate. So why should it be tolerated in new product development? 

08/24/2014 - 3:19pm

One recurring theme throughout the day’s sessions revolved around the importance of capturing the millennial shopper.

08/24/2014 - 3:10pm

IMS Health VP industry relations Doug Long briefed a packed house of NACDS TSE attendees on the latest trends shaping the U.S. pharmaceutical market.

08/22/2014 - 10:18am

In the age of omnichannel retail, brick-and-mortar stores, more than any other channel, are still the most important part of a successful omnichannel approach to retail, according to a recent report by consulting group A.T. Kearney.

08/22/2014 - 10:00am

What if you could replicate the physical in-store experience on the Web? The concept sounds incredibly powerful.

08/21/2014 - 1:35pm

There are a number of growth drivers across the digestives space, starting with the biggest proton-pump inhibitor to make its way from behind the pharmacy bench to over-the-counter aisles since the original “Purple Pill” was switched in 2003.

08/21/2014 - 10:59am

Restricting access to samples of generic biological drugs would lead to nearly $140 million in lost savings for every $1 billion in biologics sales, Matrix Global Advisors said.

08/21/2014 - 10:56am

The generic drug industry — and by extension, patients across the United States — is being adversely impacted by what some are calling branded drug makers’ abuse of risk evaluation and mitigation strategies, or REMS.